US FDA declines to approve Merck and Eisai’s liver cancer combo therapy
The FDA's complete response letter cited lack of sufficient evidence that the Keytruda-Lenvima combination therapy had a…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
Eisai
Biogen and Eisai revive plans for Alzheimer’s drug, surprising market
The field of experimental Alzheimer’s treatments is littered with high-profile failures, with many major drugmakers abandoning the…
Glenmark Pharmaceuticals receives tentative ANDA approval for Rufinamide tablets USP
Under the terms of a settlement agreement between Glenmark and Eisai, Glenmark will be permitted to market this product in the US…